This inventor holds 1 USPTO granted patent. Top assignee: Proteina, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Youjin Na - Innovator in Protein-Protein Interaction Analysis
Introduction
Youjin Na is a prominent inventor based in Seongnam, South Korea. He has made significant contributions to the field of protein-protein interaction analysis, which is crucial for understanding cellular signaling pathways. His innovative work has the potential to enhance personalized medicine by tailoring therapeutic agents to individual patients.
Latest Patents
Youjin Na holds a patent for a "Method and apparatus for analysis of protein-protein interaction." This patent discloses a method for analyzing the activation state of a signaling pathway in a cell or tissue through protein-protein interaction analysis. It also includes a method for selecting a tailored personal therapeutic agent and monitoring the efficacy of a therapeutic agent using the analysis method. The device designed for this purpose further exemplifies his innovative approach to biotechnology. He has 1 patent to his name.
Career Highlights
Youjin Na is currently employed at Proteina, Inc., where he continues to advance research in protein interactions. His work is instrumental in developing new methodologies that can lead to breakthroughs in therapeutic applications. His dedication to research and innovation has positioned him as a key figure in his field.
Collaborations
Youjin Na collaborates with various professionals in the biotechnology sector, including his coworker, Hong Won Lee. Their combined expertise fosters an environment of innovation and discovery, contributing to the advancement of their research initiatives.
Conclusion
Youjin Na's contributions to the field of protein-protein interaction analysis highlight the importance of innovation in biotechnology. His work not only enhances our understanding of cellular processes but also paves the way for personalized therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile